arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

HERON THERAPEUTICS, INC. /DE/

HRTX

$0.28 ▼ -0.02 (-5.18%) at close

18 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

HERON THERAPEUTICS, INC. /DE/ faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $46.7M

Dividend Yield —

Revenue Growth 7.4% ↘

Op. Margin -1.6% ↗

ROIC -14.0% ↘

FCF / Share $-0.17 ↘

Trailing P/E —

Price / Book 3.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$154.90M

↑ +7.4% —

Net Income Profit after all expenses

$-20.20M

↓ -48.7% —

Operating Margin Operating profit as % of sales

-1.6%

↑ +79.5% 25th

FCF / Share Free cash flow per share

$-0.17

↓ -5.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	7.4% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-8%)	13.6% Good → Good Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+70%)	18.0% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+125%)	24.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+209%)	-2.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-132%)	-39.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-591%)	88.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1005%)	151.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1798%)	2305.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+28719%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-33.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	88.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	52.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	25.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-48.7% Weak ↓ Weak Declining Year-over-year change in net income	87.7% Excellent ↑ Excellent Improving Year-over-year change in net income	39.3% Excellent ↑ Excellent Improving Year-over-year change in net income	17.5% Good ↑ Good Improving Year-over-year change in net income	2.9% Caution ↑ Caution Improving Year-over-year change in net income	-11.0% Weak ↓ Weak Declining Year-over-year change in net income	-14.5% Weak ↑ Weak Improving Year-over-year change in net income	9.4% Fair ↑ Fair Improving Year-over-year change in net income	-14.1% Weak ↑ Weak Improving Year-over-year change in net income	-77.4% Weak ↓ Weak Declining Year-over-year change in net income	-27.8% Weak ↑ Weak Improving Year-over-year change in net income	-38.1% Weak ↑ Weak Improving Year-over-year change in net income	-136.8% Weak ↓ Weak Declining Year-over-year change in net income	-97.6% Weak ↓ Weak Declining Year-over-year change in net income	-60.8% Weak Weak Year-over-year change in net income	26.7% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	-5.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	63.6% Excellent Excellent Year-over-year change in free cash flow	68.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	12.9% Good ↑ Good Improving Compound annual revenue growth over 3 years	18.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	12.7% Good ↑ Good Improving Compound annual revenue growth over 3 years	-9.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	3.7% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	42.3% Excellent Excellent Compound annual revenue growth over 3 years	385.1% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	11.8% Good ↓ Good Declining Compound annual revenue growth over 5 years	-0.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	10.4% Good ↓ Good Declining Compound annual revenue growth over 5 years	28.5% Excellent Excellent Compound annual revenue growth over 5 years	132.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	-1.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-111%)	-8.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-153%)	-87.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-680%)	-162.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1181%)	-252.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1782%)	-257.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1816%)	-144.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1062%)	-237.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1683%)	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-13.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-209%)	-9.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-178%)	-87.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-825%)	-169.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1509%)	-255.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2230%)	-256.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2237%)	-140.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1269%)	-230.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2024%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-18.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-16.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-47.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-138.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-239.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-216.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-90.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-259.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.38x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.78x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-14.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	27.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	257.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-1016.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-221.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-76.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-117.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	635.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-64.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-93.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-55.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-596.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-1.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-49.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-69.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-64.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-253.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-70.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-97.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-56.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-341.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-140.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1039%)	40.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+169%)	—	—	-284.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1997%)	-96.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-741%)	-50.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-438%)	-48.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-422%)	-150.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1104%)	—	-82.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-651%)	-121.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-907%)	-80.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-635%)	-45.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-400%)	-75.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-600%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Interest Coverage (x)	-0.39x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-28.60x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-70.60x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-90.39x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-120.02x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-143.13x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-68.84x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-49.42x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-64.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-101.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-84.06x Weak Weak Operating income divided by interest expense Optimal: > 5x	-65.77x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	$-28.65M	$-25.80M	$-28.68M	$-15.36M	$-90.54M	$-105.14M	$-71.90M	$-31.84M	$-144.58M	$-13.41M	$-75.18M	$-72.67M	$-72.29M	$-53.51M	$-17.97M	$-2.11M	$-7.59M	$-9.97M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$0.93	$0.95	$0.92	$0.99	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.12	$-0.09	$-0.80	$-1.67	$-2.24	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.17	$-0.16	$-0.44	$-1.37	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.08	$-0.22	$-0.23	$0.11	$0.76	$2.59	$4.47	$4.74	$2.03	—	$3.27	$2.16	$2.92	$3.43	$0.08	$0.03	—	—
Tangible Book Value per Share (USD)	$0.08	$-0.22	$-0.23	$0.11	$0.76	$2.59	$4.47	$4.74	$2.03	—	$3.27	$2.16	$2.92	$3.43	$0.08	$0.03	—	—
Basic Weighted Avg Shares (shares)	166.71M	152.45M	138.13M	108.88M	98,471	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$141.97M	$117.56M	$109.09M	$123.08M	$183.37M	$211.69M	$382.36M	$355.23M	$124.89M	$23.41M	$115.02M	$60.11M	$65.93M	$49.94M	$14.55M	$941.00K	—	—
Total Equity (USD)	$14.33M	$-33.65M	$-33.97M	$13.57M	$77.57M	$236.49M	$403.83M	$370.16M	$131.14M	$-21.25M	$118.11M	$63.06M	$68.94M	$51.82M	$15.75M	$1.32M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$154.90M	$144.28M	$127.04M	$107.67M	$86.35M	$88.64M	$145.97M	$77.47M	$30.77M	$1.28M	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$2.31M	$2.49M	$2.90M	$2.89M	$3.02M	$2.85M	$2.04M	$1.51M	$1.53M	$1.10M	$700.00K	$578.00K	$333.00K	$197.00K	—	—	—	—
Net Income, GAAP (USD)	$-20.20M	$-13.58M	$-110.56M	$-182.02M	$-220.68M	$-227.28M	$-204.75M	$-178.84M	$-197.48M	$-173.14M	$-97.59M	$-76.37M	$-55.28M	$-23.35M	$-11.81M	$-7.35M	$-10.03M	—
Operating Cash Flow (USD)	$-27.59M	$-22.53M	$-58.79M	$-146.91M	$-203.35M	$-184.82M	$-124.58M	$-191.81M	$-170.30M	$-134.10M	$-78.53M	$-60.28M	$-40.76M	$-17.01M	$-7.72M	$-5.48M	$-11.00M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters

HERON THERAPEUTICS, INC. /DE/

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HRTX with peers